Save your place

Sign in to WhoBought

Please try again later.

LENZ Therapeutics, Inc. (LENZ) institutional ownership

Latest close $5.72 Jul 29, 2026
Market cap$855M 52-week range SectorHealthcare
Funds holding · Q1 2026
160
reported LENZ position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
85 buyers · 75 sellers

LENZ Therapeutics, Inc. (LENZ) price and institutional activity

Dates

Q1 2026

$0 bought by 85 investors
Squarepoint Ops LLCAberdeen Group PLC +83 more
$0 sold by 75 investors
UBS Group AGT. Rowe Price Associates +73 more
Bought Sold Totals per quarter; hover a bar for the names.

LENZ Therapeutics, Inc. (LENZ) institutional activity · 85

Investor Type Est. change Change Δ Own Date
Squarepoint Ops LLC · Added
Change +1.0M Date Q1 2026
Squarepoint Ops LLC Added· Q1 2026 +1.0M Q1 2026
Aberdeen Group PLC · Added
Change +667K Date Q1 2026
Aberdeen Group PLC Added· Q1 2026 +667K Q1 2026
Bank of America Corp · Added
Change +433K Date Q1 2026
Bank of America Corp Added· Q1 2026 +433K Q1 2026
Morgan Stanley · Added
Change +415K Date Q1 2026
Morgan Stanley Added· Q1 2026 +415K Q1 2026
Blue Owl Capital Holdings LP · Added
Change +357K Date Q1 2026
Blue Owl Capital Holdings LP Added· Q1 2026 +357K Q1 2026
Millennium Management LLC · Added
Change +330K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +330K Q1 2026
BlackRock · Added
Change +285K Date Q1 2026
BlackRock Added· Q1 2026 +285K Q1 2026
Two Sigma Investments, LP · Added
Change +208K Δ Own +70.7% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +208K +70.7% Q1 2026
C Worldwide Group Holding A · Added
Change +200K Date Q1 2026
C Worldwide Group Holding A Added· Q1 2026 +200K Q1 2026
AQR Capital Management LLC · New
Change +140K Date Q1 2026
AQR Capital Management LLC New· Q1 2026 +140K Q1 2026
Xtx Topco Ltd · Added
Change +135K Date Q1 2026
Xtx Topco Ltd Added· Q1 2026 +135K Q1 2026
Marshall Wace, LLP · Added
Change +125K Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +125K Q1 2026
Y-Intercept (hong Kong) Ltd · Added
Change +118K Date Q1 2026
Y-Intercept (hong Kong) Ltd Added· Q1 2026 +118K Q1 2026
Silvercrest Asset Management Group LLC · Added
Change +109K Date Q1 2026
Silvercrest Asset Management Group LLC Added· Q1 2026 +109K Q1 2026
Affinity Asset Advisors, LLC · New
Change +100K Date Q1 2026
Affinity Asset Advisors, LLC New· Q1 2026 +100K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 85

Famous investor activity in LENZ Therapeutics, Inc. (LENZ)

LENZ Therapeutics, Inc. (LENZ) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Ra Capital Management, L.P. · Director Grant (A) 22K
Owned 22K Trade date Jun 15, 2026 Filed date Jun 15, 2026
Ra Capital Management, L.P. Director Grant (A) 22K 22K Jun 15, 2026 Jun 15, 2026
George Jeffrey P. · Director Grant (A) 22K
Owned 22K Trade date Jun 15, 2026 Filed date Jun 15, 2026
George Jeffrey P. Director Grant (A) 22K 22K Jun 15, 2026 Jun 15, 2026
Drapkin Kimberlee C. · Director Grant (A) 22K
Owned 22K Trade date Jun 15, 2026 Filed date Jun 15, 2026
Drapkin Kimberlee C. Director Grant (A) 22K 22K Jun 15, 2026 Jun 15, 2026
McCollum James W. · Director Grant (A) 22K
Owned 22K Trade date Jun 15, 2026 Filed date Jun 15, 2026
McCollum James W. Director Grant (A) 22K 22K Jun 15, 2026 Jun 15, 2026
Thunen Shelley B. · Director Grant (A) 22K
Owned 22K Trade date Jun 15, 2026 Filed date Jun 15, 2026
Thunen Shelley B. Director Grant (A) 22K 22K Jun 15, 2026 Jun 15, 2026
Guerard Frederic · Director Grant (A) 22K
Owned 22K Trade date Jun 15, 2026 Filed date Jun 15, 2026
Guerard Frederic Director Grant (A) 22K 22K Jun 15, 2026 Jun 15, 2026
Scheiner Zachary · Director Grant (A) 22K
Owned 22K Trade date Jun 15, 2026 Filed date Jun 15, 2026
Scheiner Zachary Director Grant (A) 22K 22K Jun 15, 2026 Jun 15, 2026
George Jeffrey P. · Director Buy +$50K
Price $8.92 Qty +6K Owned 6K Trade date Mar 27, 2026 Filed date Mar 30, 2026
George Jeffrey P. Director Buy $8.92 +6K +$50K 6K Mar 27, 2026 Mar 30, 2026
Schimmelpennink Evert B. · Director, Officer Buy +$251K
Price $8.95 Qty +28K Owned 77K Trade date Mar 27, 2026 Filed date Mar 30, 2026
Schimmelpennink Evert B. Director, Officer Buy $8.95 +28K +$251K 77K Mar 27, 2026 Mar 30, 2026
Chevallard Daniel R. · Officer Buy +$64K
Price $8.57 Qty +8K Owned 13K Trade date Mar 27, 2026 Filed date Mar 30, 2026
Chevallard Daniel R. Officer Buy $8.57 +8K +$64K 13K Mar 27, 2026 Mar 30, 2026
Olsson Shawn · Officer 2 operations 98K
Owned 14K Trade date Jan 2, 2026 Filed date Jan 6, 2026
Olsson Shawn Officer 2 operations 98K 14K Jan 2, 2026 Jan 6, 2026
Odrich Marc · Officer 2 operations 98K
Owned 84K Trade date Jan 2, 2026 Filed date Jan 6, 2026
Odrich Marc Officer 2 operations 98K 84K Jan 2, 2026 Jan 6, 2026
Chevallard Daniel R. · Officer 2 operations 98K
Owned 84K Trade date Jan 2, 2026 Filed date Jan 6, 2026
Chevallard Daniel R. Officer 2 operations 98K 84K Jan 2, 2026 Jan 6, 2026
Schimmelpennink Evert B. · Director, Officer Grant (A) 358K
Owned 358K Trade date Jan 2, 2026 Filed date Jan 6, 2026
Schimmelpennink Evert B. Director, Officer Grant (A) 358K 358K Jan 2, 2026 Jan 6, 2026
Olsson Shawn · Officer 2 operations −$261K
Price $25.74–$26.37 Qty −10K Owned 5K Trade date Nov 17, 2025 Filed date Nov 19, 2025
Olsson Shawn Officer 2 operations $25.74–$26.37 −10K −$261K 5K Nov 17, 2025 Nov 19, 2025
15 of 25
15 of 25 Sign in to continue to older insider transactions.

LENZ Therapeutics, Inc. (LENZ) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Ra Capital Management, L.P. 4.3M
% of shares outstanding 16.6% Filing date Mar 28, 2024
Ra Capital Management, L.P. 4.3M 16.6% Mar 28, 2024
Alpha Wave Ventures Gp, Ltd 3.6M
% of shares outstanding 14.1% Filing date Mar 28, 2024
Alpha Wave Ventures Gp, Ltd 3.6M 14.1% Mar 28, 2024
Samsara Biocapital, L.P. 7.8M
% of shares outstanding 13.5% Filing date Feb 14, 2022
Samsara Biocapital, L.P. 7.8M 13.5% Feb 14, 2022
FMR LLC 6.2M
% of shares outstanding 10.8% Filing date Feb 9, 2022
FMR LLC 6.2M 10.8% Feb 9, 2022
Versant Venture Capital Vi, L.P. 2.1M
% of shares outstanding 7.6% Filing date Nov 8, 2024
Versant Venture Capital Vi, L.P. 2.1M 7.6% Nov 8, 2024
Ridgeback Capital Investments L.P. 2.0M
% of shares outstanding 7.2% Filing date Jul 29, 2024
Ridgeback Capital Investments L.P. 2.0M 7.2% Jul 29, 2024
Porteus Matthew 3.5M
% of shares outstanding 6.1% Filing date Feb 14, 2022
Porteus Matthew 3.5M 6.1% Feb 14, 2022
Blackrock, Inc. 1.8M
% of shares outstanding 5.8% Filing date Apr 27, 2026
Blackrock, Inc. 1.8M 5.8% Apr 27, 2026
8 of 11

LENZ Therapeutics, Inc. (LENZ) ownership FAQ

Who owns LENZ?

160 reporting institutions disclosed LENZ position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.